Metabolic effects of bezafibrate in mitochondrial disease.

MLA

Steele, Hannah, et al. “Metabolic Effects of Bezafibrate in Mitochondrial Disease.” EMBO Molecular Medicine, vol. 12, no. 3, Mar. 2020, p. e11589. EBSCOhost, https://doi.org/10.15252/emmm.201911589.

APA

Steele, H., Gomez-Duran, A., Pyle, A., Hopton, S., Newman, J., Stefanetti, R. J., Charman, S. J., Parikh, J. D., He, L., Viscomi, C., Jakovljevic, D. G., Hollingsworth, K. G., Robinson, A. J., Taylor, R. W., Bottolo, L., Horvath, R., & Chinnery, P. F. (2020). Metabolic effects of bezafibrate in mitochondrial disease. EMBO Molecular Medicine, 12(3), e11589. https://doi.org/10.15252/emmm.201911589

Chicago

Steele, Hannah, Aurora Gomez-Duran, Angela Pyle, Sila Hopton, Jane Newman, Renae J Stefanetti, Sarah J Charman, et al. 2020. “Metabolic Effects of Bezafibrate in Mitochondrial Disease.” EMBO Molecular Medicine 12 (3): e11589. doi:10.15252/emmm.201911589.